These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15125843)

  • 1. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV; Nominé Y; Yu X; Juranic N; Macura S; Chen J; Mer G
    Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
    Varma AK; Brown RS; Birrane G; Ladias JA
    Biochemistry; 2005 Aug; 44(33):10941-6. PubMed ID: 16101277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA; Gojobori T; Imanishi T
    Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations.
    Cantor S; Drapkin R; Zhang F; Lin Y; Han J; Pamidi S; Livingston DM
    Proc Natl Acad Sci U S A; 2004 Feb; 101(8):2357-62. PubMed ID: 14983014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function.
    Cantor SB; Bell DW; Ganesan S; Kass EM; Drapkin R; Grossman S; Wahrer DC; Sgroi DC; Lane WS; Haber DA; Livingston DM
    Cell; 2001 Apr; 105(1):149-60. PubMed ID: 11301010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y; Botuyan MV; Bajzer Z; Owen WG; Caride AJ; Wasielewski E; Mer G
    Biochemistry; 2008 Sep; 47(37):9866-79. PubMed ID: 18717574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
    Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
    Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a novel mutation in exon 20 of the BRCA1 gene.
    Chakraborty A; Katarkar A; Chaudhuri K; Mukhopadhyay A; Basak J
    Cell Mol Biol Lett; 2013 Dec; 18(4):631-8. PubMed ID: 24297685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M; Hamel N; Carvalho MA; Birrane G; Soni A; van Beers EH; Joosse SA; Wong N; Novak D; Quenneville LA; Grist SA; ; Nederlof PM; Goldgar DE; Tavtigian SV; Monteiro AN; Ladias JA; Foulkes WD
    Eur J Hum Genet; 2008 Jul; 16(7):820-32. PubMed ID: 18285836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between BRCT repeats and phosphoproteins: tangled up in two.
    Glover JN; Williams RS; Lee MS
    Trends Biochem Sci; 2004 Nov; 29(11):579-85. PubMed ID: 15501676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BACH1 is a DNA repair protein supporting BRCA1 damage response.
    Peng M; Litman R; Jin Z; Fong G; Cantor SB
    Oncogene; 2006 Apr; 25(15):2245-53. PubMed ID: 16462773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
    Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
    J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS; Jeffrey PD; Cantor SB; Finnin MS; Livingston DM; Pavletich NP
    Genes Dev; 2002 Mar; 16(5):583-93. PubMed ID: 11877378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of BRCA1/BRCA2-associated helicase BACH1 is required for timely progression through S phase.
    Kumaraswamy E; Shiekhattar R
    Mol Cell Biol; 2007 Oct; 27(19):6733-41. PubMed ID: 17664283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.